Navigation Links
Memorandum of Agreement: Training State Regulators to Advance the Quality of Orthopaedic Care for China
Date:11/14/2012

BEIJING, Nov. 14, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today signed a Memorandum of Agreement with the Beijing Drug Administration (BJDA) to jointly hold training sessions at Montagne, Zimmer's wholly-owned Chinese subsidiary.  The trainings will be dedicated to the mutual sharing of knowledge and expertise in research, development, quality and regulation related to musculoskeletal health.  The partnership aims to allow BJDA to gain industry knowledge and to understand Zimmer and its products through dialogues and trainings undertaken by its State Inspectors. The goal of the agreement also includes strengthening production and inspection expertise at Chinese medical device companies to ensure the delivery of safe and quality orthopaedic medical devices.

Under the terms of the Agreement, which is a first with the Chinese government for Zimmer, BJDA will provide the Company with professional training regarding Chinese laws and regulations related to the manufacture and sale of medical devices.  Zimmer, in turn, will share proven experience in areas including research, development, inspection, clinical use and quality systems management.  The Company is recognized internationally for the quality of its professional education training provided to surgeons through the Zimmer Institute.

"This collaboration with the Beijing Drug Administration marks a new milestone for Zimmer in China.  Worldwide, Zimmer is a recognized leader in the development of products, services and professional training that helps patients overcome pain and regain mobility," said David Dvorak, President and CEO of Zimmer.  "Cooperating with BJDA, we are strengthening our commitment to the Chinese market.  The knowledge and expertise Zimmer's employees and the State Regulators will share with one another will help to elevate orthopaedic medicine in China."

"Beijing Drug Administration is pleased that Zimmer is cooperating with us in this initiative," said Ms. Lu Aili, Deputy Director General of Beijing Drug Administration.  

"The trainings provide a platform by which both sides will be able to gain from each other's strengths related to medical devices, especially in the area of orthopaedic reconstructive.  Overall, BJDA is committed to working with all our partners and industry stakeholders to achieve the goals set forth in the 12th Five-Year Plan of upgrading the healthcare industry and ensuring citizens' health and quality of life."

China is among the fast-growing emerging markets for medical devices, with high unmet needs in the treatment of musculoskeletal diseases, including arthritis.  Primarily associated with the elderly, arthritis is on the rise as China's population ages.  According to recently released statistics by the China National Committee on Aging, the number of Chinese senior citizens is expected to increase from the current 185 million to 487 million, or 35 percent of the population, by 2053.

This joint effort by Zimmer and the BJDA to hold training sessions lays the groundwork for additional opportunities to share knowledge in the near future.   This collaboration will further enhance the safety and effectiveness of medical devices, provide musculoskeletal health solutions and improve the quality of life for patients in China.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 9,000 employees worldwide.

For more information, please visit our website at www.zimmer.com.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
2. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
3. Diplomat Specialty Pharmacys 2012 Physician Satisfaction Survey Results Affirm Success of Companys Education & Training Program
4. Effective Market Research Training and Development Programs Set the Stage for Global Organizational Success
5. Mike Golic, ESPN Radio Personality and Former Philadelphia Eagle, Holds Pre-Season "Training Camp" for People With Type 2 Diabetes
6. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
7. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
8. Cleveland Clinic and IBM Work to Advance Watsons Use in the Medical Training Field
9. SAM Medical Products Offers Product Training at the Point of Care
10. AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education
11. AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):